Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;16(5):521-32.
doi: 10.1586/14737159.2016.1146593. Epub 2016 Feb 24.

Toward clinical genomics in everyday medicine: perspectives and recommendations

Affiliations

Toward clinical genomics in everyday medicine: perspectives and recommendations

Susan K Delaney et al. Expert Rev Mol Diagn. 2016.

Abstract

Precision or personalized medicine through clinical genome and exome sequencing has been described by some as a revolution that could transform healthcare delivery, yet it is currently used in only a small fraction of patients, principally for the diagnosis of suspected Mendelian conditions and for targeting cancer treatments. Given the burden of illness in our society, it is of interest to ask how clinical genome and exome sequencing can be constructively integrated more broadly into the routine practice of medicine for the betterment of public health. In November 2014, 46 experts from academia, industry, policy and patient advocacy gathered in a conference sponsored by Illumina, Inc. to discuss this question, share viewpoints and propose recommendations. This perspective summarizes that work and identifies some of the obstacles and opportunities that must be considered in translating advances in genomics more widely into the practice of medicine.

Keywords: Personalized medicine; clinical genomics; exome; genetic testing; genome; genomic data; practice standards; precision medicine; sequencing.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Defining CGES use cases along the clinical care continuum and appropriate evidentiary thresholds for each.
Figure 2.
Figure 2.
Harnessing the network effect of genome sequencing.
Figure 3.
Figure 3.
Virtuous cycles possible for genomic data.
Figure 4.
Figure 4.
Stakeholders collaborating to catalyze precision medicine.

Similar articles

Cited by

References

    1. What Is Genetic Testing? Genetics Home Reference. Bethesda (MD): 2016. [cited 2016 Jan 16;]. http://ghr.nlm.nih.gov/handbook/testing/genetictesting NIH/U.S. National Library of Medicine. Available from.
    1. Biesecker LG, Green RC. Diagnostic clinical genome and exome sequencing. N Eng J Med. 2014;371(12):1170. - PubMed
    1. Prada CE, Gonzaga-Jauregui C, Tannenbaum R. Clinical utility of whole-exome sequencing in rare diseases: galactosialidosis. Eur J Med Genet. 2014;57(7):339–344. - PMC - PubMed
    1. Tsurusaki Y, Kobayashi Y, Hisano M. The diagnostic utility of exome sequencing in Joubert syndrome and related disorders. J of Hum Genet. 2013;58(2):113–115. - PubMed
    1. Pyle A, Smertenko T, Bargiela D. Exome sequencing in undiagnosed inherited and sporadic ataxias. Brain. 2015;138(2):276–283. - PMC - PubMed

Publication types

MeSH terms

Substances